Diagnostics Products Overview
Precise & ultra-sensitive diagnosis
–
The key
to Successful Cancer Treatment
Precise
diagnosis is the key to successful
treatment. Biomarkers, i.e.
components of our body cells that
can be used as indicators for the
disease, will enable doctors to
determine which cancer type a
patient has much more quickly and
specifically.
Chikujee is also working to identify
tumor markers that will detect tumor
cells long before the first symptoms
become apparent. This information
will help physicians to initiate
targeted and effective treatment
without delay, thereby enhancing
patient well-being and decreasing
the cost to the healthcare system.
Chikujee’s Solutions for Cancer Diagnostics
Chikujee’s Solutions for Cancer
Diagnostics
To identify cancer at its earliest
and more treatable stage, different
types of cancer diagnostic tests are
used to:
-
Screen an asymptomatic
population for the early
detection of cancer
-
Screen at-risk individuals
-
Diagnose a primary cancer and
identify the cancer subtype
-
Predict prognosis and direct
treatment
-
Monitor treatment efficacy and
disease progression or
recurrence
-
Earlier detection and treatment
subsequently decreases cancer
mortality.
Chikujee
Therapeutics contributes to the
efficient and patient-friendly
management of cancer by providing a
wide range of high-value tools for
screening, diagnosis and monitoring
of different cancer types.
Our diagnostic products give doctors
more specific information about
clinically relevant aspects of
disease, enabling more targeted
treatment planning and monitoring of
an individual patient’s response to
therapy.
Chikujee strives to improve the
diagnosis and assessment of cancer
by effectively moving new
technologies and scientific
knowledge into clinical practice.
A road map for non-invasive
ultra-sensitive detection has been
developed to ensure that development
of the next generation of laboratory
tests is efficient and effective.